| Preventing type 2 diabetes: systematic review of studies of cost-effectiveness of lifestyle programmes and metformin, with and without screening, for pre-diabetes S Roberts, E Barry, D Craig, M Airoldi, G Bevan, T Greenhalgh BMJ open 7 (11), e017184, 2017 | 119 | 2017 |
| Four days later in Cincinnati: Longitudinal tests of hyperbolic discounting D Read, S Frederick, M Airoldi Acta psychologica 140 (2), 177-185, 2012 | 88 | 2012 |
| The global challenge for skin health RJ Hay, M Augustin, CEM Griffiths, W Sterry, ... British Journal of Dermatology 172 (6), 1469-1472, 2015 | 78 | 2015 |
| Nuclear risk management on stage: a decision analysis perspective on the UK's Committee on Radioactive Waste Management A Morton, M Airoldi, LD Phillips Risk Analysis: An International Journal 29 (5), 764-779, 2009 | 76 | 2009 |
| STAR—people-powered prioritization: a 21st-century solution to allocation headaches M Airoldi, A Morton, JAE Smith, G Bevan Medical decision making 34 (8), 965-975, 2014 | 62 | 2014 |
| Adjusting life for quality or disability: stylistic difference or substantial dispute? M Airoldi, A Morton Health economics 18 (11), 1237-1247, 2009 | 58 | 2009 |
| Walking the contractual tightrope: A transaction cost economics perspective on social impact bonds C FitzGerald, E Carter, R Dixon, M Airoldi Public Money & Management 39 (7), 458-467, 2019 | 41 | 2019 |
| Disinvestments in practice: overcoming resistance to change through a sociotechnical approach with local stakeholders M Airoldi Journal of Health Politics, Policy and Law 38 (6), 1149-1171, 2013 | 34 | 2013 |
| Intertemporal tradeoffs priced in interest rates and amounts: A study of method variance D Read, M Airoldi, G Loewe Department of Operational Research, London School of Economics and Political …, 2005 | 33 | 2005 |
| Building the tools for public services to secure better outcomes: Collaboration, Prevention, Innovation E Carter, C FitzGerald, R Dixon, C Economy, T Hameed, M Airoldi Government Outcomes Lab, University of Oxford, Blavatnik School of Government, 2018 | 31 | 2018 |
| Modelling the impact on avoidable cardiovascular disease burden and costs of interventions to lower SBP in the England population H Dodhia, K Phillips, MI Zannou, M Airoldi, G Bevan Journal of hypertension 30 (1), 217-226, 2012 | 27 | 2012 |
| Building the tools for public services to secure better outcomes: Collaboration, Prevention E Carter, C FitzGerald, R Dixon, C Economy, T Hameed, M Airoldi Innovation, 2018 | 21 | 2018 |
| Estimating health and productivity gains in England from selected interventions G Bevan, M Airoldi, A Morton, M Oliveira, J Smith London: The Health Foundation, 2007 | 19 | 2007 |
| Portfolio decision analysis for population health M Airoldi, A Morton Portfolio decision analysis: Improved methods for resource allocation, 359-381, 2011 | 15 | 2011 |
| Healthcare prioritisation at the local level: a socio-technical approach M Airoldi, AD Morton, J Smith, G Bevan Department of Management, London School of Economics and Political Science, 2011 | 14 | 2011 |
| Have we ‘stretched’social impact bonds too far? An empirical analysis of SIB design in practice C Economy, E Carter, M Airoldi International Public Management Journal 26 (3), 413-436, 2023 | 12 | 2023 |
| Requisite models for strategic commissioning: the example of type 1 diabetes M Airoldi, G Bevan, A Morton, M Oliveira, J Smith Health Care Management Science 11, 89-110, 2008 | 10 | 2008 |
| Deriving optimal value from each system M Gray, M Airoldi, G Bevan, P McCulloch Journal of the Royal Society of Medicine 110 (7), 283-286, 2017 | 9 | 2017 |
| Using an epidemiological model to investigate unwarranted variation: the case of ventilation tubes for otitis media with effusion in England L Schang, C De Poli, M Airoldi, A Morton, N Bohm, M Lakhanpaul, ... Journal of health services research & policy 19 (4), 236-244, 2014 | 9 | 2014 |
| Gains in QALYs vs DALYs averted: the troubling implications of using residual life expectancy M Airoldi London School of Economics and Political Science, 2007 | 9 | 2007 |
